GAMMA Investing
IRMD icon

GAMMA Investing’s iRadimed IRMD Stock Holding History

GAMMA Investing’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.93K Sell
34
-8
-19% -$719 ﹤0.01% 3847
2026
Q2 		$4.01K Buy
42
+2
+5% +$182 ﹤0.01% 3565
2026
Q1 		$3.85K Buy
40
+7
+21% +$700 ﹤0.01% 3463
2025
Q4 		$3.21K Hold
33
– – ﹤0.01% 3451
2025
Q3 		$2.35K Hold
33
– – ﹤0.01% 3410
2025
Q2 		$1.97K Buy
33
+26
+371% +$1.42K ﹤0.01% 3408
2025
Q1 		$367 Buy
7
+6
+600% +$337 ﹤0.01% 3713
2024
Q4 		$55 Buy
+1
New +$53 ﹤0.01% 3761

Other funds holding IRMD

Copeland Capital Management
Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return
Davidson Capital Management
Davidson Capital Management Corpus Christi, Texas $604M AUM 18.09% 1-Year Est. Return
Isthmus Partners
Isthmus Partners Madison, Wisconsin $1.04B AUM 19.97% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Kings Path Partners
Kings Path Partners Sugar Land, Texas $380M AUM 12.42% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
James Investment Research
James Investment Research Alpha, Ohio $936M AUM 24.49% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

GAMMA Investing's IRMD Position: Q3 2026 in Review

GAMMA Investing reduced its iRadimed (IRMD) stake by 19% in Q3 2026, selling an estimated $719 and leaving 34 shares worth $2.93K. The position accounts for ﹤0.01% of the portfolio, ranked #3847.

GAMMA Investing first reported a position in IRMD in Q4 2024 and has held it in 8 quarters since. The position peaked at $4.01K in Q2 2026. 32 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.

  • GAMMA Investing held 34 shares of iRadimed worth $2.93K as of Q3 2026.
  • GAMMA Investing sold 8 iRadimed shares in Q3 2026, an estimated $719.
  • iRadimed made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3847 holding.
  • GAMMA Investing first reported a position in iRadimed in Q4 2024 and has held it in 8 quarters since.
  • GAMMA Investing's iRadimed position peaked at $4.01K in Q2 2026.
  • 32 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.